Overall survival results for trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab: Results from the phase 3 SOLSTICE study.

Thierry André, Alfredo Falcone, Yaroslav V. Shparyk, Fedor Vladimirovich Moiseenko, Eduardo Polo, Tibor Csöszi, Arinilda Silva Campos Bragagnoli, Gabor Liposits, Ewa Chmielowska, Flore Delaporte, Hasnaa Hassan, Donia Skanji, Nadia Amellal, Mark P Saunders

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Fingeraftryk

Dyk ned i forskningsemnerne om 'Overall survival results for trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab: Results from the phase 3 SOLSTICE study.'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab